Escher F., Kühl U., Lassner D. et al. (2016) Long-term out-
come of patients with virus-negative chronic myocarditis or inflammato-
ry cardiomyopathy after immunosuppressive therapy. Clin. Res. Cardiol.,
Vol. 105: 1011–1020. doi: 10.1007/s00392–016–1011-z.
27.
Fairweather D., Cooper L.T., Blauwet L.A. (2013) Sex and
gender differences in myocarditis and dilated cardiomyopathy. Curr. Pro-
bl. Cardiol., Vol. 38(1): 7–46. doi: 10.1016/j.cpcardiol.2012.07.003.
28.
Ferreira V.M., Schulz-Menger J., Holmvang G. et al. (2018)
Cardiovascular magnetic resonance in nonischemic myocardial inflamma-
tion: Expert recommendations. J. Am. Coll. Cardiol., Vol. 72(24): 3158–
3176. doi: 10.1016/j.jacc.2018.09.072.
29.
Friedrich M.G., Sechtem U., Schulz-Menger J. et al. (2009) Cardiovascular magnetic resonance in myocarditis: a JACC white
paper. J. Am. Coll. Cardiol., Vol. 53(17): 1475–1487. doi: 10.1016/j.
jacc.2009.02.007.
30.
Frustaci A., Chimenti C. (2014) Immunosupressive thera-
py in myocarditis. Circulation J., Vol. 79: 4–7. doi.org/10.1253/circj.
CJ-14–1192.
31.
Fung G., Luo H., Qiu Y. et al. (2016) Myocarditis. Circ. Res.,
Vol. 118(3): 496–514. doi: 10.1161/CIRCRESAHA.115.306573.
32.
Hase H., Saito T., Yamazaki H. et al. (2016) Successful
treatment using corticosteroids in early phase of eosinophilic myocardi-
tis with eosinophilic granulomatosis with polyangiitis. Journal of Cardi-
ology Cases, Vol. 14 (6): 177–180. doi: 10.1016/j.jccase.2016.08.006.
33.
He J., Yang L. (2019) Value of three-dimensional speckle-track-
ing imaging in detecting left ventricular systolic function in patients with
dilated cardiomyopathy. Echocardiography, Vol. 36(8): 1492–1495. doi:
10.1111/echo.14427.
34.
